Senti Biosciences Holdings Inc (SNTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 22 | 0 | 2,561 | 4,286 | 2,761 |
| Gross Profit | 22 | N/A | 2,561 | 4,286 | 2,761 |
| Operating Expenses | 68,801 | 61,039 | 95,288 | 66,370 | 43,207 |
| Operating Income | -68,779 | -61,039 | -92,727 | -62,084 | -40,446 |
| Other Income | 7,341 | 8,249 | 9,321 | 12,419 | -14,873 |
| Pre-tax Income | -61,438 | -52,790 | -83,406 | -49,665 | -55,319 |
| Net Income Continuous | -61,438 | -52,790 | -83,406 | -49,665 | -55,319 |
| Net Income Discontinuous | N/A | N/A | 12,348 | -8,545 | N/A |
| Net Income | $-61,438 | $-52,790 | $-71,058 | $-58,210 | $-55,319 |
| EPS Basic Total Ops | -2.73 | -12.03 | -16.01 | -22.30 | -190.00 |
| EPS Basic Continuous Ops | -2.73 | -11.49 | -18.80 | -19.00 | -189.97 |
| EPS Basic Discontinuous Ops | N/A | N/A | 2.79 | -3.30 | N/A |
| EPS Diluted Total Ops | -2.73 | -12.03 | -16.01 | -22.30 | -190.00 |
| EPS Diluted Continuous Ops | -2.73 | -11.49 | -18.80 | -19.00 | -189.97 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 2.79 | -3.30 | N/A |
| EPS Diluted Before Non-Recurring Items | -2.55 | -12.03 | -18.80 | -22.30 | N/A |
| EBITDA(a) | $-65,142 | $-57,201 | $-87,298 | $-58,164 | $-37,436 |